POS AM XBRL

POST EFFECTIVE REGISTRATION STATEMENT

Company: Jasper Therapeutics, Inc.
Filed: March 24, 2022
Accession Number: 0001213900-22-014845

View Document ↗ View on SEC.gov ↗